Erectile dysfunction is a common and often debilitating condition. The National Institute of Clinical Excellence (NICE) and the British Society of Sexual Medicine (BSSM) in the UK and the European Association of the Urology (EAU) have guidelines on the management of ED. This article will look at the similarities of the guidelines commenting where and how they differ.
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA, J Am Med Assoc1993; 270: 83–90.
2.
FeldmanHAGoldsteinIHatzichristouDGet al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol1994; 151: 54–61.
3.
GandagliaGBrigantiAJacksonGet al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol2014; 65: 968–978.
4.
GlinaSSharlipIDHellstromWJ. Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med2013; 10: 115–119.
5.
HackettGKellPRalphDet al. British Society for Sexual Medicine guidelines on the management of erectile dysfunction. J Sex Med2008; 5: 1841–1865.
6.
SommerFGoldsteinIKordaJB. Bicycle riding and erectile dysfunction: a review. J Sex Med2010; 7: 2346–2358.
7.
MHRA. Press release: MHRA warns about dangerous ‘herbal’ treatments. Medicines and Healthcare Products Regulatory Agency, 2011, http://www.mhra.gov.uk/
8.
MulhallJPGoldsteinIBushmakinAGet al. Validation of the erection hardness score. J Sex Med2007; 4: 1626–1634.
9.
WhooleyMAAvinsALMirandaJet al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med1997; 12: 439–445.
10.
KostisJBJacksonGRosenRet al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol2005; 96: 85M–93M.
11.
NehraAGrantmyreJNadelAet al. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol2005; 173: 2067–2071.
12.
TurekSJHastingsSMSunJKet al. Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes. Diabetes Care2013; 36: 3222–3226.
13.
NehraAJacksonGMinerMet al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc2012; 87: 766–778.
14.
DerbyCAMohrBAGoldsteinIet al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?Urology2000; 56: 302–306.
15.
HatzimouratidisKAmarEEardleyIet al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol2010; 57: 804–814.
16.
SandaMGDunnRLMichalskiJet al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med2008; 358: 1250–1261.
17.
IncrocciLJensenPT. Pelvic radiotherapy and sexual function in men and women. J Sex Med2013; 10 Suppl1: 53–64.
18.
StemberDSMulhallJP. The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer. Brachytherapy2012; 11: 87–96.
19.
SaloniaABurnettALGraefenMet al. Prevention and management of postprostatectomy sexual dysfunctions. Part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol2012; 62: 273–286.
20.
SaloniaABurnettALGraefenMet al. Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery. Eur Urol2012; 62: 261–272.
Padma-NathanHMcCulloughARLevineLAet al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impotence Res2008; 20: 479–486.
23.
GoldsteinILueTFPadma-NathanHet al. Oral sildenafil in the treatment of erectile dysfunction. 1998. J Urol2002; 167: 1197–1203; discussion 204.
24.
MooreRADerrySMcQuayHJ. Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction. BMC Urol2005; 5: 18.
25.
MoncadaIde BethencourtFRLledo-GarciaEet al. Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy. World J Urol2015; 33: 1031–1038.
26.
MontorsiFBrockGStolzenburgJUet al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol2014; 65: 587–596.
27.
BuvatJHatzichristouDBoessFGet al. Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study. Int J Clin Pract2014; 68: 1087–1099.
28.
PorstHGacciMButtnerHet al. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies. Eur Urol2014; 65: 455–464.
29.
McCulloughARBaradaJHFawzyAet al. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology2002; 60: 28–38.
30.
OjumuADobsAS. Is hypogonadism a risk factor for sexual dysfunction?J Androl2003; 24: S46–S51.
31.
AversaAIsidoriAMSperaGet al. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxford)2003; 58: 632–638.
BettocchiCPalumboFSpilotrosMet al. Patient and partner satisfaction after AMS inflatable penile prosthesis implant. J Sex Med2010; 7: 304–309.
34.
ChungESolomonMDeYoungLet al. Clinical outcomes and patient satisfaction rates among elderly male aged >/=75 years with inflatable penile prosthesis implant for medically refractory erectile dysfunction. World J Urol2014; 32: 173–177.
35.
FalconeMRolleLCerutiCet al. Prospective analysis of the surgical outcomes and patients’ satisfaction rate after the AMS Spectra penile prosthesis implantation. Urology2013; 82: 373–376.
